Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis

In multiple sclerosis (MS), experimental and ex vivo studies indicate that pathologic intra- and extracellular sodium accumulation may play a pivotal role in inflammatory as well as neurodegenerative processes. Yet, in vivo assessment of sodium in the microenvironment is hard to achieve. Here, sodiu...

Full description

Bibliographic Details
Main Authors: Konstantin Huhn, Tobias Engelhorn, Ralf A. Linker, Armin M. Nagel
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00084/full
_version_ 1818899494797836288
author Konstantin Huhn
Tobias Engelhorn
Ralf A. Linker
Armin M. Nagel
Armin M. Nagel
author_facet Konstantin Huhn
Tobias Engelhorn
Ralf A. Linker
Armin M. Nagel
Armin M. Nagel
author_sort Konstantin Huhn
collection DOAJ
description In multiple sclerosis (MS), experimental and ex vivo studies indicate that pathologic intra- and extracellular sodium accumulation may play a pivotal role in inflammatory as well as neurodegenerative processes. Yet, in vivo assessment of sodium in the microenvironment is hard to achieve. Here, sodium magnetic resonance imaging (23NaMRI) with its non-invasive properties offers a unique opportunity to further elucidate the effects of sodium disequilibrium in MS pathology in vivo in addition to regular proton based MRI. However, unfavorable physical properties and low in vivo concentrations of sodium ions resulting in low signal-to-noise-ratio (SNR) as well as low spatial resolution resulting in partial volume effects limited the application of 23NaMRI. With the recent advent of high-field MRI scanners and more sophisticated sodium MRI acquisition techniques enabling better resolution and higher SNR, 23NaMRI revived. These studies revealed pathologic total sodium concentrations in MS brains now even allowing for the (partial) differentiation of intra- and extracellular sodium accumulation. Within this review we (1) demonstrate the physical basis and imaging techniques of 23NaMRI and (2) analyze the present and future clinical application of 23NaMRI focusing on the field of MS thus highlighting its potential as biomarker for neuroinflammation and -degeneration.
first_indexed 2024-12-19T19:48:52Z
format Article
id doaj.art-71a70602b5dc4b10bf3ee889c5f61d18
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-19T19:48:52Z
publishDate 2019-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-71a70602b5dc4b10bf3ee889c5f61d182022-12-21T20:08:04ZengFrontiers Media S.A.Frontiers in Neurology1664-22952019-02-011010.3389/fneur.2019.00084429081Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple SclerosisKonstantin Huhn0Tobias Engelhorn1Ralf A. Linker2Armin M. Nagel3Armin M. Nagel4Department of Neurology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, GermanyDepartment of Neuroradiology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, GermanyDepartment of Neurology, University of Regensburg, Regensburg, GermanyDepartment of Radiology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, GermanyDivision of Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, GermanyIn multiple sclerosis (MS), experimental and ex vivo studies indicate that pathologic intra- and extracellular sodium accumulation may play a pivotal role in inflammatory as well as neurodegenerative processes. Yet, in vivo assessment of sodium in the microenvironment is hard to achieve. Here, sodium magnetic resonance imaging (23NaMRI) with its non-invasive properties offers a unique opportunity to further elucidate the effects of sodium disequilibrium in MS pathology in vivo in addition to regular proton based MRI. However, unfavorable physical properties and low in vivo concentrations of sodium ions resulting in low signal-to-noise-ratio (SNR) as well as low spatial resolution resulting in partial volume effects limited the application of 23NaMRI. With the recent advent of high-field MRI scanners and more sophisticated sodium MRI acquisition techniques enabling better resolution and higher SNR, 23NaMRI revived. These studies revealed pathologic total sodium concentrations in MS brains now even allowing for the (partial) differentiation of intra- and extracellular sodium accumulation. Within this review we (1) demonstrate the physical basis and imaging techniques of 23NaMRI and (2) analyze the present and future clinical application of 23NaMRI focusing on the field of MS thus highlighting its potential as biomarker for neuroinflammation and -degeneration.https://www.frontiersin.org/article/10.3389/fneur.2019.00084/fullmultiple sclerosismagnetic resonance imagingsodium MRI23Na MRIneurodegenerationbiomarker
spellingShingle Konstantin Huhn
Tobias Engelhorn
Ralf A. Linker
Armin M. Nagel
Armin M. Nagel
Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
Frontiers in Neurology
multiple sclerosis
magnetic resonance imaging
sodium MRI
23Na MRI
neurodegeneration
biomarker
title Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
title_full Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
title_fullStr Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
title_full_unstemmed Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
title_short Potential of Sodium MRI as a Biomarker for Neurodegeneration and Neuroinflammation in Multiple Sclerosis
title_sort potential of sodium mri as a biomarker for neurodegeneration and neuroinflammation in multiple sclerosis
topic multiple sclerosis
magnetic resonance imaging
sodium MRI
23Na MRI
neurodegeneration
biomarker
url https://www.frontiersin.org/article/10.3389/fneur.2019.00084/full
work_keys_str_mv AT konstantinhuhn potentialofsodiummriasabiomarkerforneurodegenerationandneuroinflammationinmultiplesclerosis
AT tobiasengelhorn potentialofsodiummriasabiomarkerforneurodegenerationandneuroinflammationinmultiplesclerosis
AT ralfalinker potentialofsodiummriasabiomarkerforneurodegenerationandneuroinflammationinmultiplesclerosis
AT arminmnagel potentialofsodiummriasabiomarkerforneurodegenerationandneuroinflammationinmultiplesclerosis
AT arminmnagel potentialofsodiummriasabiomarkerforneurodegenerationandneuroinflammationinmultiplesclerosis